Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience

Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience

Typhoid fever is a significant health concern in low- and middle-income countries, with millions of cases and thousands of deaths each year. Typhoid Conjugate Vaccines, such as Typbar TCV®, have been developed to provide longer-lasting protection for young children. This publication includes the rea...

Full description

Saved in:
Bibliographic Details
Main Authors: Krishna Mohan Vadrevu, Siddharth Reddy Chiteti, Raju Dugyala, Vinay Kumar Aileni, Akhila. Kunta, Badri Narayan Patnaik, Raches Ella
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Typbar TCV®
typhoid conjugate vaccine
typhoid
Typhim Vi
salmonella Typhi
Immunogenicity
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2507912
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2025.2507912

Similar Items